Potassium Phosphates (Potassium Phosphate, Monobasic Potassium Phosphate, Dibasic)
**Product type:** Human Prescription Drug
**Active ingredient:** DIBASIC POTASSIUM PHOSPHATE; MONOBASIC POTASSIUM PHOSPHATE
**Strength:** 236; 224 mg/mL; mg/mL
**Dosage form:** Injection, Solution, Concentrate
**Route:** Intravenous
**Labeler:** Fresenius Kabi USA, LLC
**Marketing category:** NDA (NDA212832)
**Pharmacologic class:** Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC]
/api/v1/systems/ndc_fda/nodes/65219-054Hierarchy Explorer
Cross-system equivalences0
No cross-system equivalences mapped for this node.